End-of-day quote
Shenzhen S.E.
18:00:00 2024-05-30 EDT
|
5-day change
|
1st Jan Change
|
10.15
CNY
|
-3.15%
|
|
-8.81%
|
-20.77%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,260
|
2,198
|
2,566
|
2,611
|
2,003
|
2,335
|
Enterprise Value (EV)
1 |
1,989
|
1,965
|
2,326
|
2,363
|
1,631
|
1,955
|
P/E ratio
|
30.8
x
|
24.7
x
|
27.8
x
|
30.4
x
|
23.7
x
|
45.8
x
|
Yield
|
4.79%
|
2.46%
|
3.31%
|
1.63%
|
4.15%
|
1.95%
|
Capitalization / Revenue
|
4.36
x
|
4.09
x
|
4.71
x
|
3.48
x
|
3.88
x
|
6.26
x
|
EV / Revenue
|
3.84
x
|
3.65
x
|
4.27
x
|
3.15
x
|
3.16
x
|
5.24
x
|
EV / EBITDA
|
21.4
x
|
16.3
x
|
18.2
x
|
19.5
x
|
14.9
x
|
29
x
|
EV / FCF
|
77.4
x
|
31.9
x
|
36.9
x
|
77.1
x
|
11.4
x
|
32.3
x
|
FCF Yield
|
1.29%
|
3.13%
|
2.71%
|
1.3%
|
8.81%
|
3.1%
|
Price to Book
|
3.69
x
|
3.88
x
|
4.41
x
|
4.21
x
|
2.89
x
|
3.51
x
|
Nbr of stocks (in thousands)
|
183,112
|
183,106
|
179,447
|
179,429
|
180,092
|
182,302
|
Reference price
2 |
12.34
|
12.01
|
14.30
|
14.55
|
11.12
|
12.81
|
Announcement Date
|
19-04-28
|
20-04-19
|
21-04-26
|
22-04-29
|
23-04-07
|
24-04-26
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
518.3
|
538
|
544.7
|
749.3
|
516.5
|
372.8
|
EBITDA
1 |
92.79
|
120.9
|
127.5
|
121
|
109.4
|
67.36
|
EBIT
1 |
71.46
|
95.01
|
101.1
|
93.78
|
84.88
|
46.18
|
Operating Margin
|
13.79%
|
17.66%
|
18.57%
|
12.52%
|
16.43%
|
12.39%
|
Earnings before Tax (EBT)
1 |
84.22
|
103.3
|
107.6
|
99.03
|
96.59
|
60.76
|
Net income
1 |
73.4
|
88.29
|
91.9
|
85.93
|
84.55
|
50.88
|
Net margin
|
14.16%
|
16.41%
|
16.87%
|
11.47%
|
16.37%
|
13.65%
|
EPS
2 |
0.4008
|
0.4852
|
0.5148
|
0.4793
|
0.4692
|
0.2800
|
Free Cash Flow
1 |
25.71
|
61.5
|
63.12
|
30.64
|
143.7
|
60.51
|
FCF margin
|
4.96%
|
11.43%
|
11.59%
|
4.09%
|
27.81%
|
16.23%
|
FCF Conversion (EBITDA)
|
27.7%
|
50.89%
|
49.5%
|
25.33%
|
131.27%
|
89.82%
|
FCF Conversion (Net income)
|
35.02%
|
69.66%
|
68.68%
|
35.65%
|
169.9%
|
118.92%
|
Dividend per Share
2 |
0.5917
|
0.2959
|
0.4734
|
0.2367
|
0.4615
|
0.2500
|
Announcement Date
|
19-04-28
|
20-04-19
|
21-04-26
|
22-04-29
|
23-04-07
|
24-04-26
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
271
|
234
|
240
|
247
|
372
|
380
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
25.7
|
61.5
|
63.1
|
30.6
|
144
|
60.5
|
ROE (net income / shareholders' equity)
|
12.1%
|
15%
|
16%
|
14.3%
|
12.9%
|
7.51%
|
ROA (Net income/ Total Assets)
|
6.71%
|
9.14%
|
9.68%
|
8.17%
|
7.1%
|
3.93%
|
Assets
1 |
1,095
|
965.5
|
949.7
|
1,051
|
1,191
|
1,295
|
Book Value Per Share
2 |
3.350
|
3.090
|
3.250
|
3.460
|
3.850
|
3.650
|
Cash Flow per Share
2 |
0.2000
|
0.1800
|
0.2800
|
0.3800
|
0.3700
|
0.3300
|
Capex
1 |
26.5
|
17.8
|
19.2
|
4.08
|
19.7
|
14.5
|
Capex / Sales
|
5.11%
|
3.31%
|
3.53%
|
0.54%
|
3.81%
|
3.89%
|
Announcement Date
|
19-04-28
|
20-04-19
|
21-04-26
|
22-04-29
|
23-04-07
|
24-04-26
|
|
1st Jan change
|
Capi.
|
---|
| -20.77% | 254M | | +17.07% | 66.31B | | -0.29% | 48.46B | | +21.61% | 43.27B | | +27.43% | 27.41B | | +9.25% | 19.26B | | -2.14% | 16.61B | | +9.75% | 16.58B | | -15.01% | 14.41B | | -30.22% | 14.02B |
Other Specialty Chemicals
|